IDO1 and neoplasm: It is known that the tumor microenvironment is enriched with indoleamine-pyrrole 2,3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine, an endogenous ligand for the aryl hydrocarbon receptor (AHR).